NCT00097240CompletedNot Applicable
The Raptiva Pregnancy Registry: An Observational Study of the Use and Safety of Raptiva (Efalizumab) During Pregnancy
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Genentech, Inc.
- Enrollment
- 18
- Locations
- 1
Study Overview
Brief Summary
The Raptiva Pregnancy Registry was a prospective observational study established to obtain data on pregnancy outcomes of women who were exposed to Raptiva.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Eligibility Criteria
- Sex
- Female
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Recruiting
Not Applicable
Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control PopulationPregnancy RelatedAtopic DermatitisNCT06259669Incyte Corporation958
Completed
Not Applicable
Rebif® Pregnancy RegistryMultiple SclerosisNCT00338741EMD Serono36
Completed
Not Applicable
Pregnancy Exposure Registry for Avonex (Interferon Beta-1a)Prenatal Exposure Delayed EffectsPregnancyMultiple SclerosisNCT00168714Biogen329
Recruiting
Not Applicable
Relugolix Pregnancy Registry: An Observational Study of the Safety of Relugolix-Containing Therapy Exposure in Pregnant Women and Their OffspringPregnancy RelatedPregnancy ComplicationsPregnancy, High RiskNCT05739123Sumitomo Pharma Switzerland GmbH728
Completed
Not Applicable
A Study of Pregnancy and Pregnancy Outcomes in Women With Breast Cancer Treated With Trastuzumab, Pertuzumab in Combination With Trastuzumab, or Ado-Trastuzumab EmtansinePregnancyBreast CancerNCT00833963Genentech, Inc.20